Aemetis, Inc. (NASDAQ:AMTX) Short Interest Update

Aemetis, Inc. (NASDAQ:AMTX) saw a significant increase in short interest in June. As of June 15th, there was short interest totalling 5,710,000 shares, an increase of 5.4% from the May 31st total of 5,420,000 shares. Based on an average trading volume of 697,900 shares, the days-to-cover ratio is currently 8.2 days.

Aemetis Trading Up 3.8 %

NASDAQ AMTX opened at $2.97 on Wednesday. Aemetis has a 12 month low of $2.75 and a 12 month high of $8.99. The stock has a market cap of $131.87 million, a P/E ratio of -2.54 and a beta of 1.32. The stock’s fifty day moving average price is $3.52 and its 200-day moving average price is $3.92.

Aemetis (NASDAQ:AMTX) last released its earnings results on Thursday, May 9th. The specialty chemicals company reported ($0.58) EPS for the quarter, missing analysts’ consensus estimates of ($0.43) by ($0.15). The firm had revenue of $72.63 million during the quarter, compared to analysts’ expectations of $78.74 million. As a group, analysts forecast that Aemetis will post -1.59 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on AMTX shares. HC Wainwright reiterated a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a report on Friday, May 10th. Truist Financial reiterated a “hold” rating and issued a $4.00 price objective (up previously from $3.50) on shares of Aemetis in a report on Monday, May 13th. Finally, StockNews.com upgraded Aemetis to a “sell” rating in a report on Monday, June 3rd. One analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Aemetis presently has an average rating of “Hold” and an average price target of $12.25.

Insider Activity at Aemetis

In related news, Director John R. Block sold 51,580 shares of the company’s stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $3.49, for a total transaction of $180,014.20. Following the completion of the transaction, the director now owns 14,001 shares in the company, valued at $48,863.49. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 16.44% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Aemetis

A number of institutional investors have recently modified their holdings of AMTX. State Board of Administration of Florida Retirement System purchased a new stake in shares of Aemetis during the first quarter valued at $84,000. SG Americas Securities LLC purchased a new stake in shares of Aemetis during the first quarter valued at $60,000. Citigroup Inc. boosted its position in shares of Aemetis by 10,391.3% during the third quarter. Citigroup Inc. now owns 75,013 shares of the specialty chemicals company’s stock valued at $311,000 after buying an additional 74,298 shares during the last quarter. Finally, Stifel Financial Corp boosted its position in shares of Aemetis by 58.0% during the third quarter. Stifel Financial Corp now owns 691,445 shares of the specialty chemicals company’s stock valued at $2,870,000 after buying an additional 253,745 shares during the last quarter. 27.02% of the stock is owned by hedge funds and other institutional investors.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.